These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33431252)

  • 1. A state-level needs analysis of community pharmacy point-of-care testing.
    Gallimore CE; Porter AL; Barnett SG; Portillo E; Zorek JA
    J Am Pharm Assoc (2003); 2021; 61(3):e93-e98. PubMed ID: 33431252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding access to HIV testing through Canadian community pharmacies: findings from the APPROACH study.
    Kelly DV; Kielly J; Hughes C; Gahagan J; Asghari S; Hancock S; Burt K; Smyczek P; Charlton C; Nguyen H
    BMC Public Health; 2020 May; 20(1):639. PubMed ID: 32380978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing Community Pharmacists' Perception on Readiness to Initiate Point-of-Care Testing for SARS-CoV-2 in New York State During the Pandemic.
    Ngwu RO; Lindeau R; Bielecki LM; Daly CJ
    J Pharm Pract; 2024 Apr; 37(2):324-334. PubMed ID: 36242519
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of an accredited training program on implementation of point-of-care testing in community pharmacies.
    Smith MG; Rains L
    J Am Pharm Assoc (2003); 2020; 60(6):e140-e144. PubMed ID: 32448745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacists' Opinions on the Implementation of HIV and HepC Point-of-Care-Testing in a U.S. Pharmacy Chain.
    So E; Brands M; Suomala E; Ogden B; Riss J; Cernasev A; Schommer J
    Innov Pharm; 2019; 10(1):. PubMed ID: 34007531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient awareness, willingness, and barriers to point-of-care hepatitis C screening in community pharmacy.
    Brewer A; Hanna C; Eckmann L; Schadler A; Divine H
    J Am Pharm Assoc (2003); 2018; 58(4S):S69-S72.e1. PubMed ID: 30006188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptation of POCT for pharmacies to reduce risk and optimize access to care in HIV, the APPROACH study protocol: examining acceptability and feasibility.
    Kielly J; Kelly DV; Hughes C; Day K; Hancock S; Asghari S; Gahagan J; Marra C; Nguyen H
    Pilot Feasibility Stud; 2018; 4():59. PubMed ID: 30788134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential for Pharmacy-Public Health Collaborations Using Pharmacy-Based Point-of-Care Testing Services for Infectious Diseases.
    Gubbins PO; Klepser ME; Adams AJ; Jacobs DM; Percival KM; Tallman GB
    J Public Health Manag Pract; 2017; 23(6):593-600. PubMed ID: 27997479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of unmet demand for pharmacists: a survey of rural community pharmacies in Wisconsin.
    Gadkari AS; Mott DA; Kreling DH; Bonnarens JK
    J Am Pharm Assoc (2003); 2008; 48(5):598-609. PubMed ID: 18826899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing community pharmacy services in health professional shortage areas across Wisconsin.
    Look KA; Black P; Arzt J; Crahan J; Helgeson CB; Lucey MS; Lee M; Rox KR; Portillo E
    J Am Pharm Assoc (2003); 2024; 64(2):506-511.e3. PubMed ID: 37940092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating advanced pharmacy technician roles in the provision of point-of-care testing.
    Hill H; Cardosi L; Henson L; Wasson M; Fountain M; Desselle S; Hohmeier KC
    J Am Pharm Assoc (2003); 2020; 60(4):e64-e69. PubMed ID: 32217084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National survey of pharmacy-based immunization services.
    Westrick SC; Patterson BJ; Kader MS; Rashid S; Buck PO; Rothholz MC
    Vaccine; 2018 Sep; 36(37):5657-5664. PubMed ID: 30049631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring pharmacists' perceptions regarding influenza and streptococcal testing within a chain pharmacy.
    Dulaney K; Hohmeier K; Fisher C; Cardosi L; Wasson M
    J Am Pharm Assoc (2003); 2018; 58(4):438-441.e1. PubMed ID: 29691199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy.
    Gubbins PO; Klepser ME; Dering-Anderson AM; Bauer KA; Darin KM; Klepser S; Matthias KR; Scarsi K
    J Am Pharm Assoc (2003); 2014; 54(2):163-71. PubMed ID: 24632931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innovating the Model for Student Pharmacists to Increase Access to Hepatitis C Testing (Project IMPACT).
    Januszka J; Notarianni V; Devenny E; Harris E
    J Am Pharm Assoc (2003); 2023; 63(4):1217-1221. PubMed ID: 37037394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross-sectional survey of enhanced and extended professional services in community pharmacies: A pharmacy perspective.
    Sim TF; Wright B; Hattingh L; Parsons R; Sunderland B; Czarniak P
    Res Social Adm Pharm; 2020 Apr; 16(4):511-521. PubMed ID: 31300355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Jersey Pharmacists' Perceptions on Performing COVID-19 Testing in Community Pharmacy Practice Sites.
    Brust-Sisti LA; Armanious ME; Ohlinger K; Patel J; Lodhia T; Sturgill MG; Volino LR
    J Pharm Pract; 2023 Aug; 36(4):853-860. PubMed ID: 35357961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing point-of-care testing through standardized training and redeployment of pharmacy technicians in the community setting.
    Pope S; Hill H; Cardosi L; Henson L; Wasson M; Stallworth S; Ward K; Desselle SP; Hohmeier KC
    Explor Res Clin Soc Pharm; 2021 Jun; 2():100034. PubMed ID: 35481116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding scope: Impact and preferred implementation strategies for statewide test and treat protocols.
    Smith MG; Abdullah E
    J Am Pharm Assoc (2003); 2023; 63(5):1617-1622. PubMed ID: 37327998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point-of-care testing in pharmacies-An evaluation of the service from the lens of resource-based theory of competitive advantage.
    Pontinha VM; Wagner TD; Holdford DA
    J Am Pharm Assoc (2003); 2021; 61(2):e45-e54. PubMed ID: 33309067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.